Home > Cashflow Statement > CONCORD BIOTECH

CONCORD BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-113 Cr₹-99 Cr₹-99 Cr₹-85 Cr₹-100 Cr

What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?

The latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH is ₹-113 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-113 Cr
Mar2025₹-99 Cr
Mar2024₹-99 Cr
Mar2023₹-85 Cr
Mar2022₹-100 Cr

How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-113 Cr
Negative
Mar2025 ₹-99 Cr
Negative
Mar2024 ₹-99 Cr
Negative
Mar2023 ₹-85 Cr
Negative
Mar2022 ₹-100 Cr -

Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹12,864.2 Cr -3.1% -10.6% -18.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,150.0 Cr 0.8% -2.1% 4.8% Stock Analytics
DIVIS LABORATORIES ₹266,265.0 Cr 4.9% 7.9% 54.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr 1.6% -2.7% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,351.0 Cr 2.6% 14.2% 3.9% Stock Analytics
CIPLA ₹112,474.0 Cr 2.4% 3.4% -12% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-3.1%

-10.6%

-18.8%

SENSEX

4.5%

6.1%

-9.3%


You may also like the below Video Courses